GFP
IMGN

Gryphon Financial Partners’s Immunogen Inc IMGN Stock Holding History

Gryphon Financial Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-137
Closed -$1K – 876
2018
Q2 		$1K Hold
137
– – ﹤0.01% 949
2018
Q1 		$1K Hold
137
– – ﹤0.01% 947
2017
Q4 		$1K Buy
+137
New +$845 ﹤0.01% 993

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Gryphon Financial Partners's IMGN Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Immunogen Inc (IMGN) in Q3 2018, closing a stake of 137 shares — an estimated $1K sold.

Gryphon Financial Partners first reported a position in IMGN in Q4 2017 and held it in 3 quarters. The position peaked at $1K in Q2 2018. 208 funds tracked by Wall St. Rank hold IMGN as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Immunogen Inc position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 137 Immunogen Inc shares in Q3 2018, an estimated $1K.
  • Gryphon Financial Partners first reported a position in Immunogen Inc in Q4 2017 and held it in 3 quarters.
  • Gryphon Financial Partners's Immunogen Inc position peaked at $1K in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.